Given the overexpression of YTHDF1 in TAMs and its role in cancer progression [20], downregulating YTHDF1 in TAMs is expected to reduce M2-type macrophage formation, reshaping the TME for potent antitumor effects. Here, YTHDF1 is linked to cancer.